{"entity":{"id":"da-pair-lecanemab-mri","kind":"pairing","name":"Lecanemab with MRI monitoring","aka":[],"tldr":"Amyloid antibodies are used with scheduled MRI checks for ARIA, not as a standalone infusion without imaging follow-up.","summary":"This pairing is a teaching node: the medicine and the scan belong together. It is not a local protocol.","asOf":"2026-09-21","links":[{"label":"FDA Leqembi","url":"https://www.fda.gov/news-events/press-announcements/fda-converts-novel-alzheimers-disease-treatment-traditional-approval"}],"tags":["dementia-atlas"],"related":[],"cancers":["alzheimers-disease"],"sections":[],"technologies":["da-tech-mri"],"targets":[],"drugs":["da-lecanemab"],"companies":[],"institutions":[],"pathways":[],"terms":["da-term-aria"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"a":"da-lecanemab","b":"da-tech-mri","rationale":"ARIA monitoring on MRI is part of using an amyloid antibody, not an optional extra.","evidence":"The US lecanemab label requires MRI monitoring for ARIA. See the FDA approval communication.","pairingType":"diagnostic-therapeutic"},"route":"/pairings/da-pair-lecanemab-mri/","neighbours":{"cancer":[{"id":"alzheimers-disease","kind":"cancer","name":"Alzheimer’s disease","route":"/diagnoses/alzheimers-disease/"}],"technology":[{"id":"da-tech-mri","kind":"technology","name":"Brain MRI","route":"/technologies/da-tech-mri/"}],"drug":[{"id":"da-lecanemab","kind":"drug","name":"Lecanemab","route":"/drugs/da-lecanemab/"}],"term":[{"id":"da-term-aria","kind":"term","name":"ARIA","route":"/terms/da-term-aria/"}]}}